• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Financial Officer Clement Ryan Moore covered exercise/tax liability with 62,002 shares and converted options into 211,240 shares, increasing direct ownership by 96% to 304,705 units (SEC Form 4)

    8/5/25 9:24:57 PM ET
    $SLQT
    Specialty Insurers
    Finance
    Get the next $SLQT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Clement Ryan Moore

    (Last) (First) (Middle)
    C/O SELECTQUOTE, INC.
    6800 WEST 115TH STREET, SUITE 2511

    (Street)
    OVERLAND PARK KS 66211

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SelectQuote, Inc. [ SLQT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    08/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.01 per share 08/01/2025 M 16,227 A $0 171,694 D
    Common Stock, par value $0.01 per share 08/01/2025 M 88,889 A $0 260,583 D
    Common Stock, par value $0.01 per share 08/01/2025 M 63,897 A $0 324,480 D
    Common Stock, par value $0.01 per share 08/01/2025 M 9,817 A $0 334,297 D
    Common Stock, par value $0.01 per share 08/01/2025 M 11,111 A $0 345,408 D
    Common Stock, par value $0.01 per share 08/01/2025 M 21,299 A $0 366,707 D
    Common Stock, par value $0.01 per share 08/02/2025 F 62,002(1) D $1.74 304,705 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units(2) (3) 08/01/2025 M 16,227 (4) 08/01/2032 Common Stock, par value $0.01 per share 16,227 (3) 0 D
    Restricted Stock Units(2) (3) 08/01/2025 M 88,889 (5) 09/13/2033 Common Stock, par value $0.01 per share 88,889 (3) 88,889 D
    Restricted Stock Units(2) (3) 08/01/2025 M 63,897 (6) 10/28/2034 Common Stock, par value $0.01 per share 63,897 (3) 127,796 D
    Price-Vested Restricted Stock Units(7) (8) 08/01/2025 M 9,817 (9) 08/01/2027 Common Stock, par value $0.01 per share 9,817 (8) 88,353 D
    Price-Vested Restricted Stock Units(7) (8) 08/01/2025 M 11,111 (10) 09/13/2028 Common Stock, par value $0.01 per share 11,111 (8) 111,111 D
    Price-Vested Restricted Stock Units(7) (8) 08/01/2025 M 21,299 (11) 10/28/2029 Common Stock, par value $0.01 per share 21,299 (8) 170,394 D
    Restricted Stock Units(2) (3) 08/01/2025 A 270,000 (4) 08/01/2035 Common Stock, par value $0.01 per share 270,000 (3) 270,000 D
    Price-Vested Restricted Stock Units(7) (8) 08/01/2025 A 270,000 (12) 08/01/2030 Common Stock, par value $0.01 per share 270,000 (8) 270,000 D
    Explanation of Responses:
    1. Represents shares surrendered to the issuer to satisfy withholding taxes owed upon the vesting of price-vested units and time-based restricted stock units previously granted to the recipient.
    2. Represents restricted stock units of SelectQuote, Inc. (the "Company") granted to the recipient pursuant to the Company's 2020 Omnibus Incentive Plan (the "Plan").
    3. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.
    4. The restricted stock units vest ratably in three annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.
    5. The restricted stock units vest ratably in three annual installments commencing on August 1, 2024, subject to the recipient's continued employment with the Company through the applicable vesting date.
    6. The restricted stock units vest ratably in three annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date.
    7. Represents price-vested restricted stock units of the Company ("PVUs") granted to the recipient pursuant to the Plan.
    8. Each PVU represents the contingent right to receive one share of the Company's common stock, par value $0.01 per share, upon the Company's common stock reaching certain predetermined average trading prices, subject to applicable vesting conditions.
    9. The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock reaching each of $4.00, $7.50, $10.00, and $12.50 during the five-year performance period. The number of PVUs reported on this line reflects the portion of the total PVU award that vested on the transaction date following the achievement of the $4.00 price hurdle.
    10. The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2024, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.50, $5.00, $7.50, and $10.00 during the five-year performance period. The number of PVUs reported on this line reflects the portion of the total PVU award that vested on the transaction date following the achievement of the $2.50 price hurdle.
    11. The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2025, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $3.13, $6.00, and $9.00 during the five-year performance period. The number of PVUs reported on this line reflects the portion of the total PVU award that vested on the transaction date following the achievement of the $3.13 price hurdle.
    12. The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-third of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.50, $4.00, and $6.00 during the five-year performance period.
    Remarks:
    /s/ Daniel A. Boulware, Attorney-in-Fact 08/05/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SLQT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SLQT

    DatePrice TargetRatingAnalyst
    5/21/2025$2.75Hold
    Jefferies
    9/30/2024$4.50Buy
    Craig Hallum
    2/29/2024$5.00Outperform
    Noble Capital Markets
    4/1/2022$4.00Neutral
    Credit Suisse
    2/8/2022$9.00 → $5.00Equal Weight
    Barclays
    2/8/2022$13.00 → $3.00Sector Perform
    RBC Capital
    2/8/2022$20.00 → $4.00Overweight → Neutral
    Piper Sandler
    2/8/2022$14.00 → $4.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $SLQT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Devine Denise L bought $14,460 worth of shares (4,000 units at $3.62), increasing direct ownership by 1% to 318,583 units (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    3/19/25 4:54:26 PM ET
    $SLQT
    Specialty Insurers
    Finance

    SEC Form 4: Matthews Joshua Brandon bought $113,295 worth of shares (97,500 units at $1.16), increasing direct ownership by 32% to 400,937 units

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    9/18/23 6:29:01 PM ET
    $SLQT
    Specialty Insurers
    Finance

    SEC Form 4: Grant William Thomas Iii bought $179,250 worth of shares (150,000 units at $1.20), increasing direct ownership by 9% to 1,913,851 units

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    9/18/23 6:28:20 PM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Clement Ryan Moore covered exercise/tax liability with 62,002 shares and converted options into 211,240 shares, increasing direct ownership by 96% to 304,705 units (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    8/5/25 9:24:57 PM ET
    $SLQT
    Specialty Insurers
    Finance

    President, SelectQuote Senior Matthews Joshua Brandon converted options into 144,321 shares, increasing direct ownership by 30% to 625,944 units (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    8/5/25 9:24:49 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Chief Accounting Officer Fisher Stephanie D. converted options into 59,651 shares and covered exercise/tax liability with 25,266 shares, increasing direct ownership by 49% to 104,582 units (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    8/5/25 9:24:35 PM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SelectQuote to Release Fiscal Fourth Quarter and Full Year 2025 Earnings on August 21

    SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fourth quarter and full year 2025 financial results before market open on Thursday, August 21, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (August 21, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I547808. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes

    8/7/25 7:30:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    SelectQuote Unveils New Program Designed to Elevate Health Plan Performance by Improving Medication Adherence for Polychronic Medicare Beneficiaries

    SelectQuote, Inc. (NYSE:SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with a regional health plan that demonstrated over 90% adherence, strengthening HEDIS Star ratings across the triple-weighted cholesterol, diabetes and hypertension measures. The Company plans to expand to additional payers this calendar year a

    7/17/25 7:00:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    SelectQuote Mourns the Passing of Tom Grant, Vice Chairman of the Board of Directors

    SelectQuote, Inc. (NYSE:SLQT) announced today that William Thomas (Tom) Grant II, Vice Chairman and former President of SelectQuote, passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing SelectQuote's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business. His strategic insights and dedication were pivotal to the company's success. Tom also personally touched the lives of thousands of SelectQuote associates and their families with his wit, warmth, and ever-present smile. "Tom's mark on SelectQuote was profound a

    7/2/25 4:15:00 PM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on SelectQuote with a new price target

    Jefferies initiated coverage of SelectQuote with a rating of Hold and set a new price target of $2.75

    5/21/25 8:59:27 AM ET
    $SLQT
    Specialty Insurers
    Finance

    Craig Hallum initiated coverage on SelectQuote with a new price target

    Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50

    9/30/24 8:47:10 AM ET
    $SLQT
    Specialty Insurers
    Finance

    Noble Capital Markets initiated coverage on SelectQuote with a new price target

    Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00

    2/29/24 8:29:44 AM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by SelectQuote Inc.

    SCHEDULE 13G - SelectQuote, Inc. (0001794783) (Subject)

    8/5/25 2:56:07 PM ET
    $SLQT
    Specialty Insurers
    Finance

    SelectQuote Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - SelectQuote, Inc. (0001794783) (Filer)

    7/29/25 5:20:21 PM ET
    $SLQT
    Specialty Insurers
    Finance

    SelectQuote Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SelectQuote, Inc. (0001794783) (Filer)

    7/2/25 5:26:27 PM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    Leadership Updates

    Live Leadership Updates

    View All

    SelectQuote Names Ryan Clement as Chief Financial Officer

    Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur

    2/22/23 8:00:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    Financials

    Live finance-specific insights

    View All

    SelectQuote to Release Fiscal Fourth Quarter and Full Year 2025 Earnings on August 21

    SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fourth quarter and full year 2025 financial results before market open on Thursday, August 21, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (August 21, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I547808. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes

    8/7/25 7:30:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2025 Results

    Third Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $408.2 million Net income of $26.0 million Adjusted EBITDA* of $37.7 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(1) million to $28 million Adjusted EBITDA* expected in a range of $115 million to $140 million Third Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $169.4 million Adjusted EBITDA* of $45.7 million Approved Medicare Advantage policies of 168,001 Healthcare Services Revenue of $189.6 million Adjusted EBITDA* of $6.4 million 105,523 SelectRx members Li

    5/12/25 7:30:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    SelectQuote to Release Fiscal Third Quarter 2025 Earnings on May 12

    SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its third quarter 2025 financial results before market open on Monday, May 12, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 12, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I54780976. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Registratio

    5/5/25 8:00:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    $SLQT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

    SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

    1/29/24 3:26:24 PM ET
    $SLQT
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

    SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

    2/14/23 1:42:28 PM ET
    $SLQT
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

    SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

    2/1/23 4:54:05 PM ET
    $SLQT
    Specialty Insurers
    Finance